Introduction
Vancomycin-resistant enterococci (VRE) are important causes of healthcare-associated infection (HCAI) and are associated with increased mortality, lengthened hospital stays and significant economic burden. 1, 2 In 2013, cases of VRE in hospitalized patients in the USA numbered 20,000 and were associated with 1300 deaths. Of these, 77% were Enterococcus faecium (VREfm) and the remainder Enterococcus faecalis (VREfl). 3 In Europe, invasive E.
faecium isolates reported to the European antimicrobial resistance surveillance network EARS-net in 2015 numbered 9123, with glycopeptide resistance ranging from 0 to 45.8%. 4 Of 29 reporting countries, Ireland had the highest rate of VRE at 45.8%.
VRE colonization and environmental contamination are associated with transmission to other patients. 5, 6 and infection prevention and control (IPC) measures, including active surveillance cultures (ASC), isolation of VRE-positive patients and contact precautions are recognized as important. 1 In Ireland, ASC for VRE is recommended for intensive care unit (ICU) admissions. The reasons for Irelands high VRE rate are unknown and may be better informed by epidemiological investigations of VREfm in an Irish setting, which here has been limited to date 7 . The aims of this study were; to identify potential reservoirs of VREfm in an ICU, to investigate the clinical and molecular epidemiology of VREfm outside of outbreaks in the ICU and to assess the role of VRE ASC in this setting.
Materials and Methods

Setting
Beaumont Hospital, Dublin, is an 820 bed tertiary referral teaching hospital. It is the national referral centre for neurosurgery, cochlear implantation, neurology, and renal transplantation and is a regional referral centre for many specialties for North-East Ireland. The study took place in the 12-bedded general ICU which has six beds in an open plan area, four single rooms and two air-controlled isolation rooms (rooms 11 and 12, Figure 1 ). The two isolation rooms are occupied less frequently (e.g. due to requirements for additional nursing staff) unless clinically required for logistical reasons. As per national guidelines, patients are screened for VRE on ICU admission and weekly thereafter and are isolated with contact precautions if positive. Previously known VRE positive patients are isolated on admission.
Cleaning of the ICU environment is performed by a dedicated member of the cleaning staff who is rostered from 07.00 to 19.00h and an on-call service is available outside these times.
Bed spaces are cleaned one at a time using 1000 ppm sodium dichloroisocyanurate (Precept, Advanced Sterilization products, Ontario, Canada). Ethical approval was obtained from the Beaumont Hospital Ethics Committee.
Environmental sampling
Environmental sampling took place during seven sampling periods within a 32 month timeframe (October 2012-June 2014). During each sampling period, the environment of occupied ICU bed-spaces was sampled twice-weekly between 10.00-12.30h for three consecutive weeks. A patient bed-space was defined as the near-patient environment in isolation rooms or open-plan area from which six 'high touch' sites were sampled. Each area was swabbed using 
Recovery of VRE from environmental samples
Swabs were transferred to brain heart infusion (BHI) broth (2ml) for enrichment and incubated overnight (16- 
Pulsed field gel electrophoresis (PFGE) for VRE
Sma1-digested genomic DNA from patient and environmental VREfm and E. faecalis ATCC 29212 were subjected to PFGE based as described by Turabelidze et al 8 but with modifications as outlined in supplemental file S1.
Statistical analyses
Fisher's exact test was used to analyze categorical variables using GraphPad QuickCalcs online software. The significance of differences between the groups was expressed as two-tailed
p-values, p values of ≤ 0.05 were considered significant.
Results
Characteristics of VRE patients in the ICU
Of 157 patients sampled, 30 (19 %) were VRE colonised. Clinically relevant patient details for VRE-colonized patients are summarised in Table 1 . Eighteen patients (60%) were admitted from another ward in the hospital. Not all VRE positive patients had contemporaneous viable isolates of VRE. Of the VRE positive patients included, two were treated for invasive VRE infection, one for a catheter-related bloodstream infection (BSI) and the other for VRE surgical-site infection. They had both initially been treated with vancomycin.
Potential reservoirs of VRE in the ICU
Of 1647 Based on the number of environmental swabs taken, rates of contamination with VRE were 4.1% and 9.1% in open-plan and isolation rooms, respectively. During the study, beds 11 and 12 were used infrequently to isolate VRE-patients (two patients). Sixty nine of 157 patients (44 %) occupied beds 7-10 at least once over the study duration and 24/69 (34.8%) were colonised with VRE. In total 26/30 (86 %) of VRE-positive patients were isolated at the time of sampling.
The specific high touch ICU sites most frequently contaminated with VRE were the drip stand, bed control panel, and chart holders, together accounting for 61% of contaminated sites ( Figure 2) . The difference in the proportional recovery of VRE from any one surface was not statistically significant.
The positive impact of ASC on VRE recovery from ICU patients
The use of ASC resulted in the identification of an additional 19/157 (11.6 %) VRE- To investigate potential transmission events related to the movement of patients within the ICU, 189 unique patient and bed number associations involving 157 patients were identified (i.e. some patient's occupied more than one ICU bed over the study period).
Tracking the pattern of recovery of VRE with respect to time and bed-space revealed six possible VRE transmission events. Four of these were from patient to environment (recovery of VRE from an environmental site (bed-spaces 7, 8 and 9) which was previously negative but became positive within two to four days of a VRE-positive patient occupying the bedspace). A further two possible transmissions of VRE from environment to patient were identified. In one case the patient became VRE-positive nine days after admission and placement in an environment which sampled positive for VRE. The other involved a patient acquiring VRE having spent 48 h in a room where the environment was VRE-positive.
Molecular epidemiology of VREfm from the ICU
In total, 137 VRE isolates were recovered during this study comprising E. faecium, E.
faecalis, E. gallinarum and an isolate of Paenibacillus spp. Of these, 71 VREfm isolates were typed using PFGE which included 49 environmental and 22 patient isolates from 17 patients (some patients had more than one isolate). Analysis revealed distinct 32 PFGE types and three PFGE clusters. Clusters (A, B and C) and their association with bed-spaces and patients are summarised in Figure 3 . Clusters A (eight isolates) and B (nine isolates) were exclusively environmental isolates from multiple bed-spaces during separate sampling periods (Periods 1 and 5). Cluster A isolates were recovered within a two-day period (sampling period 1) from five bed-spaces including isolation rooms and open-plan area (beds 2, 6, 7, 8 and 9). Cluster B included nine isolates, eight recovered on a single day (sampling period 5) from three bed-spaces (beds 4, 8, 9). The ninth isolate was recovered two days later from bed 8. Cluster C contained five isolates, four patient isolates from three patients and the fifth an environmental isolate. The three patients had occupied two separate bed-spaces at different times. The environmental isolate was unrelated in space and time to the patient isolates. This patient was re-admitted to ICU having been previously VRE-colonized and developed BSI twenty days later. The two other patient isolates in this cluster were from patients who were in ICU at the same time as the first patient (sampling period 2) and one of these developed a VRE BSI one month later (this patient rectal swab contained vancomycinsusceptible E. faecium). A further two patients, in bed-spaces 9 and 11, in different sampling periods had genetically indistinguishable VRE. A detailed dendogram of VREfm isolates is provided in supplemental file S2.
Discussion
The microbiome of the ICU is variable and factors including the patient cohort, changes in staff, cleaning regimens, IPC policies and compliance, impact on microbial population dynamics. Here, the overall contamination of the ICU environment with VRE was 6.5 % of environmental sites sampled. A similar rate of 6.0 % contamination based on six high-touch surfaces in 37 ICU rooms was previously reported. 10 Notably, we did not limit our study to the bed-spaces of patients with VRE, an approach taken by others, which may yield greater numbers over longer sampling periods. For example, 21% of environmental VRE contamination was reported in the rooms of VRE-colonised patients at baseline in a US intervention study in a similar setting with similar sampling methodologies. 11 However, one intervention study, comparing multiple surfaces from rooms housing VRE-colonised and non-colonised patients, reported 23.6 % and 5% contamination, respectively, 12 higher than the rates found here of 9 % and 4.1%.
Our study confirms previous reports that surfaces close to patients and frequently touched by staff, harbour the majority of VRE. 13 The majority of VRE positive samples were recovered from isolation rooms 7-10, where VRE colonised patients were accommodated once identified as VRE-positive, and this is supported by the literature. Prior room contamination increases the risk of patient acquisition of VRE. 14 Isolation rooms 7-10 were significantly more contaminated than the open plan area. Standard size recommendations exist for ICU isolation rooms. 15 The cramped conditions in smaller sized rooms (such as beds 7-10 here), may hamper proper cleaning of the environment, which may contribute to VRE persistence.
Patients in our ICU are screened on admission and weekly thereafter for VRE and a colonization rate of 30/157 (19.1 %) was found. A recent meta-analysis reported an average VRE colonization rate of 8.8 % across 37 studies including 62959 patients at risk.
Furthermore VRE colonization on ICU admission was higher across US studies (12.3%), compared to studies from Europe (2.7%) and elsewhere. 16 While Ireland has the highest VRE BSI rate in Europe, data on ICU colonization rates are not widely available. In this study, the positive effects of ASC on VRE detection were evident. A new finding of VRE colonization was confirmed in 19/30 patients, who were subsequently isolated within the unit representing a 172% increase in detection rate with this approach. A recent Canadian longitudinal multicentre study indicated no significant impact on clinical outcomes following removal of all VRE controls, including screening. 17 While other challenges such as MRSA have received significant attention, the significant complications of VRE colonization and infection in vulnerable ICU patients in addition to the high rate of VRE invasive infection reported in Ireland, warrants the implementation of effective IPC strategies.
Molecular typing by PFGE revealed genetic diversity among patient isolates, whereas the environmental isolates showed more clonal relationships. The acquisition of resistant determinants by susceptible enterococci in the gut, under antibiotic pressure 19 may contribute to the heterogeneity observed here among patient isolates. Acquisition of vanB associated with the transposon Tn1549 by susceptible enterococci from anaerobes of the gut flora has been shown previously. 20, 21 The more clonal pattern of environmental isolates found here suggests that the environment may select for certain clones. There were limitations to this study. Because VRE transmission dynamics were monitored discontinuously for logistical and cost reasons some transmission events were not captured. Hand carriage of VRE by healthcare workers was not investigated and may contribute to VRE transmission. Genetic relatedness of a subset of study isolates (66%) was conducted by PFGE. While this was discriminatory for the purpose of identifying clusters or confirming heterogeneity, there is no standard protocol for VRE PFGE or for data interpretation. More discriminatory but expensive approaches (e.g. multi-locus sequence typing, whole genome sequencing) might have provided more robust characterization of
isolates. However, we demonstrated that the application of molecular typing (PFGE) could potentially, in real-time, provide indications of VRE transmission that could assist improved IPC measures in a setting where the physical infrastructure, i.e. limited space and too few isolation rooms, is inadequate. 8 (27) 16 (53) 64 (34-85)
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